Serum lactate and acute mesenteric ischaemia: An observational, controlled multicentre study.
Fiche publication
Date publication
août 2022
Journal
Anaesthesia, critical care & pain medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PESSAUX Patrick
Tous les auteurs :
Collange O, Lopez M, Lejay A, Pessaux P, Ouattara A, Dewitte A, Rimmele T, Girardot T, Arnaudovski D, Augustin P, Chakfe N, Tacquard C, Oulehri W, Zieleskiewicz L, Severac F, Leone M, Mertes PM
Lien Pubmed
Résumé
Early diagnosis and prompt management of acute mesenteric ischaemia (AMI) are key to survival but remain extremely difficult, due to vague and non-specific symptoms. Serum lactate (SL) is commonly presented as a useful biomarker for the diagnosis or prognosis of AMI. The aim of our study was test SL (1) as a diagnostic marker and (2) as a prognostic marker for AMI.
Mots clés
Diagnosis, prognosis, Intensive care, Lactate, Mesenteric vascular occlusion, Multiple organ failure
Référence
Anaesth Crit Care Pain Med. 2022 08 12;41(6):101141